NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $149,268 | -86.1% | 212,360 | -55.2% | 0.00% | – |
| Q4 2022 | $1,071,823 | -73.0% | 474,258 | -61.7% | 0.00% | -100.0% |
| Q3 2022 | $3,968,000 | -55.2% | 1,239,854 | -46.8% | 0.00% | -50.0% |
| Q2 2022 | $8,857,000 | +66.0% | 2,330,858 | +135.5% | 0.00% | +100.0% |
| Q1 2022 | $5,335,000 | +224.5% | 989,717 | +713.3% | 0.00% | +100.0% |
| Q4 2021 | $1,644,000 | -66.9% | 121,690 | -56.1% | 0.00% | -50.0% |
| Q3 2021 | $4,973,000 | +3.8% | 276,920 | -0.8% | 0.00% | 0.0% |
| Q2 2021 | $4,791,000 | -15.4% | 279,204 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $5,664,000 | +20.3% | 283,194 | +2.3% | 0.00% | 0.0% |
| Q4 2020 | $4,707,000 | +0.5% | 276,874 | -1.9% | 0.00% | -33.3% |
| Q3 2020 | $4,684,000 | -29.6% | 282,354 | -1.7% | 0.00% | -25.0% |
| Q2 2020 | $6,653,000 | +21.8% | 287,275 | -6.1% | 0.00% | 0.0% |
| Q1 2020 | $5,463,000 | -17.8% | 306,045 | -0.6% | 0.00% | 0.0% |
| Q4 2019 | $6,646,000 | +35.4% | 307,895 | +14.2% | 0.00% | +33.3% |
| Q3 2019 | $4,909,000 | -48.8% | 269,500 | +0.1% | 0.00% | -50.0% |
| Q2 2019 | $9,579,000 | +8.5% | 269,236 | +2.5% | 0.01% | 0.0% |
| Q1 2019 | $8,830,000 | +2.2% | 262,783 | -0.0% | 0.01% | 0.0% |
| Q4 2018 | $8,639,000 | -44.8% | 262,830 | +2.3% | 0.01% | -40.0% |
| Q3 2018 | $15,658,000 | +24.2% | 256,860 | -0.5% | 0.01% | +11.1% |
| Q2 2018 | $12,608,000 | -72.9% | 258,196 | -41.0% | 0.01% | -73.5% |
| Q1 2018 | $46,504,000 | +195.5% | 437,641 | +66.1% | 0.03% | +209.1% |
| Q4 2017 | $15,737,000 | +183.5% | 263,506 | +14.0% | 0.01% | +175.0% |
| Q3 2017 | $5,550,000 | +22.8% | 231,237 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $4,521,000 | -7.9% | 231,237 | +10.6% | 0.00% | -25.0% |
| Q1 2017 | $4,908,000 | +79.8% | 209,137 | -6.0% | 0.00% | +100.0% |
| Q4 2016 | $2,729,000 | -34.0% | 222,437 | -7.6% | 0.00% | -33.3% |
| Q3 2016 | $4,136,000 | +20.7% | 240,737 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,426,000 | +7.7% | 240,737 | +4.1% | 0.00% | 0.0% |
| Q1 2016 | $3,180,000 | -22.2% | 231,237 | -4.6% | 0.00% | 0.0% |
| Q4 2015 | $4,085,000 | +53.1% | 242,437 | -0.5% | 0.00% | +50.0% |
| Q3 2015 | $2,669,000 | -58.1% | 243,537 | -52.1% | 0.00% | -60.0% |
| Q2 2015 | $6,364,000 | +13.7% | 508,747 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $5,596,000 | +10.2% | 508,747 | +55.4% | 0.01% | +25.0% |
| Q4 2014 | $5,076,000 | -8.1% | 327,467 | -28.4% | 0.00% | -20.0% |
| Q3 2014 | $5,521,000 | +30.6% | 457,407 | +38.7% | 0.01% | +25.0% |
| Q2 2014 | $4,227,000 | +5.8% | 329,717 | -0.0% | 0.00% | +33.3% |
| Q1 2014 | $3,997,000 | +5.0% | 329,788 | -1.7% | 0.00% | 0.0% |
| Q4 2013 | $3,808,000 | +8.6% | 335,519 | -0.0% | 0.00% | 0.0% |
| Q3 2013 | $3,506,000 | -9.5% | 335,520 | 0.0% | 0.00% | -25.0% |
| Q2 2013 | $3,875,000 | – | 335,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |